| abstract |
Disclosed herein are compositions and methods related to mutant viruses, particularly mutant influenza viruses. The mutant viruses disclosed herein comprise a mutant M2 sequence and are useful in immunogenic compositions, for example as vaccines. Also disclosed herein are methods for proliferating viral mutants, compositions and cells therefor, and methods, devices, and compositions associated with vaccination. |